⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2006World Journal of GastroenterologyOpen Access

Meta-analysis on inoperable pancreatic cancer: A comparison between gemcitabine-based combination therapy and gemcitabine alone

View Full Paper

Ask AI

Bookmark

Share

Authors

DXDe-Rong XieChongqing University of Posts and Telecommunications

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

De-Rong Xie (2006) studied this question.

synapsesocial.com/papers/6a8358afdfd29b4838caa084 https://doi.org/10.3748/wjg.v12.i43.6973

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial2005 · 957 citations
2Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E22972002 · 732 citations
3Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer2006 · 686 citations
4A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer2002 · 568 citations